Understanding the Renaming of PCOS to PMOS: A Focus on Metabolic Health

Dr. Mindy Pelz discusses the recent renaming of Polycystic Ovarian Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS), emphasizing its implications for women's health. This change highlights the importance of metabolic health in addressing hormonal imbalances.

Why the Name Change Matters

PCOS has been recognized as the most prevalent hormonal disorder among women, primarily driven by insulin resistance. Dr. Pelz states that addressing this metabolic marker can alleviate many symptoms associated with the disorder. The rebranding to PMOS aims to better reflect the condition's underlying issues, as the previous name was misleading and contributed to misdiagnosis.

Key Findings from Recent Research

According to a study involving 14,000 women, 85% of those diagnosed with PMOS exhibit insulin resistance. Alarmingly, 75% of lean women with the condition also face metabolic challenges, dispelling the myth that weight is the sole indicator of metabolic health. Dr. Pelz emphasizes the need to consider insulin levels and glucose metabolism when diagnosing and treating PMOS.

The Hormonal Hierarchy

Dr. Pelz introduces the concept of the hormonal hierarchy, where sex hormones like progesterone, estrogen, and testosterone are significantly influenced by insulin levels. She stresses the importance of monitoring hemoglobin A1C and glucose-insulin balance to restore harmony among these hormones.

Practical Strategies for Managing PMOS

To effectively manage PMOS, Dr. Pelz suggests:

• Monitoring insulin and glucose levels regularly.
• Adopting a clean diet and incorporating fasting protocols.
• Understanding the interplay between metabolic health and hormonal balance.

Her own experience with patients reveals that many can resolve symptoms through dietary adjustments and lifestyle changes aimed at improving metabolic function.

Addressing Broader Health Risks

Women with PMOS face increased risks of type 2 diabetes, cardiovascular diseases, and other metabolic disorders. Dr. Pelz urges women to take control of their metabolic health, as improving it can lead to significant benefits across multiple organ systems.

Skepticism About the Timing of the Change

Despite the positive implications of renaming PCOS to PMOS, Dr. Pelz expresses skepticism regarding the timing of this change. She questions whether the shift is merely a response to emerging weight loss drugs like GLP-1s, which are now being linked to PMOS and may be covered by insurance. This raises concerns about the motivations behind the rebranding and the pharmaceutical industry's influence.

Conclusion: Empowering Women through Education

Dr. Pelz emphasizes the importance of understanding the metabolic foundations of PMOS. By focusing on metabolic health, women can take proactive steps to manage their hormonal imbalances and improve their overall health. She encourages her audience to stay informed and engaged in their health journey.

Key Takeaways

• The renaming of PCOS to PMOS reflects a deeper understanding of the condition's metabolic roots.
• Insulin resistance is a critical factor in PMOS, affecting both weight and hormonal balance.
• Women should focus on improving metabolic health through diet, fasting, and lifestyle changes.
• Awareness of metabolic syndrome can help mitigate risks associated with PMOS.
• There's skepticism about the motivations behind the name change, particularly in relation to pharmaceutical interests.

TLDR Summary

Dr. Mindy Pelz discusses the renaming of PCOS to PMOS to emphasize its metabolic underpinnings, specifically insulin resistance. She advocates for focusing on metabolic health to manage symptoms and improve overall hormonal balance.